10 results on '"Narayan, V."'
Search Results
2. Remote assessment of disease and relapse in major depressive disorder (RADAR-MDD): a multi-centre prospective cohort study protocol
- Author
-
Matcham, F., Barattieri di San Pietro, C., Bulgari, V., de Girolamo, G., Dobson, R., Eriksson, H., Folarin, A. A., Haro, J. M., Kerz, M., Lamers, F., Li, Q., Manyakov, N. V., Mohr, D. C., Myin-Germeys, I., Narayan, V., BWJH, Penninx, Ranjan, Y., Rashid, Z., Rintala, A., Siddi, S., Simblett, S. K., Wykes, T., Hotopf, M., and on behalf of the RADAR-CNS consortium
- Published
- 2019
- Full Text
- View/download PDF
3. Data quality monitoring and performance metrics of a prospective, population-based observational study of maternal and newborn health in low resource settings
- Author
-
Fernando Althabe, Narayan V Honnungar, Waldemar A. Carlo, Omrana Pasha, Dennis Wallace, Umesh Ramadurg, Edward A. Liechty, Shivanand C Mastiholi, Elwyn Chomba, Michael Hambidge, Nancy F. Krebs, Carl L. Bose, Patricia L. Hibberd, Janet Moore, Robert L. Goldenberg, Marion Koso-Thomas, Fabian Esamai, Richard J. Derman, Kodkany S Bhalachandra, Kristen Stolka, Shivaprasad S. Goudar, Ana Garces, Sangappa M. Dhaded, and Archana Patel
- Subjects
Program evaluation ,CIENCIAS MÉDICAS Y DE LA SALUD ,perinatal registry ,newborn health ,media_common.quotation_subject ,Maternal Health ,Population ,Medically Underserved Area ,Medicina Clínica ,data monitoring ,metrics ,Pregnancy ,low-income countries ,Environmental health ,Obstetrics and Gynaecology ,purl.org/becyt/ford/3.2 [https] ,Medicine ,Humans ,data quality ,Quality (business) ,Infant Health ,Prospective Studies ,Registries ,Newborn health ,education ,Developing Countries ,Perinatal Mortality ,media_common ,education.field_of_study ,Data collection ,business.industry ,Research ,1. No poverty ,Infant, Newborn ,Pregnancy Outcome ,Obstetrics and Gynecology ,Quality control ,Infant ,3. Good health ,Data Accuracy ,Maternal Mortality ,Reproductive Medicine ,Data quality ,Observational study ,Female ,purl.org/becyt/ford/3 [https] ,Metric (unit) ,Medicina Critica y de Emergencia ,business - Abstract
BACKGROUND: To describe quantitative data quality monitoring and performance metrics adopted by the Global Network´s (GN) Maternal Newborn Health Registry (MNHR), a maternal and perinatal population-based registry (MPPBR) based in low and middle income countries (LMICs). METHODS: Ongoing prospective, population-based data on all pregnancy outcomes within defined geographical locations participating in the GN have been collected since 2008. Data quality metrics were defined and are implemented at the cluster, site and the central level to ensure data quality. Quantitative performance metrics are described for data collected between 2010 and 2013. RESULTS: Delivery outcome rates over 95% illustrate that all sites are successful in following patients from pregnancy through delivery. Examples of specific performance metric reports illustrate how both the metrics and reporting process are used to identify cluster-level and site-level quality issues and illustrate how those metrics track over time. Other summary reports (e.g. the increasing proportion of measured birth weight compared to estimated and missing birth weight) illustrate how a site has improved quality over time. CONCLUSION: High quality MPPBRs such as the MNHR provide key information on pregnancy outcomes to local and international health officials where civil registration systems are lacking. The MNHR has measures in place to monitor data collection procedures and improve the quality of data collected. Sites have increasingly achieved acceptable values of performance metrics over time, indicating improvements in data quality, but the quality control program must continue to evolve to optimize the use of the MNHR to assess the impact of community interventions in research protocols in pregnancy and perinatal health. Fil: Goudar, Shivaprasad S.. KLE University. Jawaharlal Nehru Medical College; India Fil: Stolka, Kristen B.. Research Triangle Institute International; Estados Unidos Fil: Koso Thomas, Marion. Eunice Kennedy Shriver National Institute of Child Health and Human Development; Estados Unidos Fil: Honnungar, Narayan V.. KLE University. Jawaharlal Nehru Medical College; India Fil: Mastiholi, Shivanand C.. KLE University. Jawaharlal Nehru Medical College; India Fil: Ramadurg, Umesh Y.. S. Nijalingappa Medical College; India Fil: Dhaded, Sangappa M.. KLE University. Jawaharlal Nehru Medical College; India Fil: Pasha, Omrana. Aga Khan University; Pakistán Fil: Patel, Archana. Indira Gandhi Government Medical College and Lata Medical Research Foundation; India Fil: Esamai, Fabian. University School of Medicine; Kenia Fil: Chomba, Elwyn. University of Zambia; Zambia Fil: Garces, Ana. Universidad de San Carlos; Guatemala Fil: Althabe, Fernando. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Instituto de Efectividad Clínica y Sanitaria; Argentina Fil: Carlo, Waldemar A.. University of Alabama at Birmingahm; Estados Unidos Fil: Goldenberg, Robert L.. Columbia University; Estados Unidos Fil: Hibberd, Patricia L.. Massachusetts General Hospital for Children; Estados Unidos Fil: Liechty, Edward A.. Indiana University; Estados Unidos Fil: Krebs, Nancy F.. University of Colorado School of Medicine; Estados Unidos Fil: Hambidge, Michael K.. University of Colorado School of Medicine; Estados Unidos Fil: Moore, Janet L.. Research Triangle Institute International; Estados Unidos Fil: Wallace, Dennis D.. Research Triangle Institute International; Estados Unidos Fil: Derman, Richard J. Christiana Care Health Services; Estados Unidos Fil: Bhalachandra, Kodkany S.. KLE University. Jawaharlal Nehru Medical College; India Fil: Bose, Carl L.. University of North Carolina; Estados Unidos
- Published
- 2015
- Full Text
- View/download PDF
4. Pembrolizumab for metastatic melanoma in a renal allograft recipient with subsequent graft rejection and treatment response failure: a case report.
- Author
-
Kwatra, Vineet, Karanth, Narayan V., Priyadarshana, Kelum, and Charakidis, Michail
- Subjects
- *
PEMBROLIZUMAB , *METASTASIS , *GRAFT rejection , *KIDNEY transplantation , *THERAPEUTICS - Abstract
Background: Transplant patients were excluded from the pivotal phase III trials of checkpoint inhibitors in metastatic melanoma. The efficacy and toxicity profiles of checkpoint inhibitors in this cohort of patients are not well described. To the best of our knowledge, this is the first case report of a renal transplant patient with stage IV melanoma treated with a programmed cell death protein 1 checkpoint inhibitor that led to both treatment failure and renal graft rejection.Case Presentation: We present a case of a 58-year-old white man with a long-standing cadaveric renal transplant who was diagnosed with a B-Raf Proto-Oncogene, Serine/Threonine Kinase wild-type metastatic melanoma. He was treated with first-line pembrolizumab but experienced subsequent graft failure and rapid disease progression.Conclusions: This case highlights the risks associated with the administration of checkpoint inhibitors in patients with a renal transplant and on immunosuppressive therapy. More specifically, it adds to the literature indicating that, compared with the cytotoxic T-lymphocyte-associated protein 4 inhibitor ipilimumab, anti-programmed cell death protein 1 agents are more likely to lead to renal graft failure. Additionally, these novel immunotherapeutics may be ineffective in transplant patients; therefore, clinicians should be very aware of those risks and carefully consider selection of agents and full disclosure of the risks to their patients. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
5. Establishment of a Maternal Newborn Health Registry in the Belgaum District of Karnataka, India.
- Author
-
Kodkany, Bhalachandra S., Derman, Richard J., Honnungar, Narayan V., Tyagi, Naresh K., Goudar, Shivaprasad S., Mastiholi, Shivanand C., Moore, Janet L., McClure, Elizabeth M., Sloan, Nancy, and Goldenberg, Robert L.
- Subjects
CHILD health services ,REPORTING of diseases ,EVALUATION of medical care ,PREGNANCY - Abstract
Background: Pregnancy-related vital registration is important to inform policy to reduce maternal, fetal and newborn mortality, yet few systems for capturing accurate data are available in low-middle income countries where the majority of the mortality occurs. Furthermore, methods to effectively implement high-quality registration systems have not been described. The goal of creating the registry described in this paper was to inform public health policy makers about pregnancy outcomes in our district so that appropriate interventions to improve these outcomes could be undertaken and to position the district to be a leader in pregnancy-related public health research. Methods: We created a prospective maternal and newborn health registry in Belgaum, Karnataka State, India. To initiate this registry, we worked with the Ministry of Health to first establish estimated birth rates and define the catchment areas of the clusters, working within the existing health system and primary health centers. We also undertook household surveys to identify women likely to become pregnant. We then implemented monitoring measures to ensure high quality and completeness of the maternal newborn health registry. All pregnant women in the catchment area were identified, consented and enrolled during pregnancy, with follow-up visits to ascertain pregnancy outcomes and mother/infant status at 42-days postpartum. Results: From 2008 through 2014, we demonstrated continued improvements in both the coverage for enrollment and accuracy of reporting pregnancy outcomes within the defined catchment area in Belgaum, India. Nearly 100% of women enrolled had follow-up at birth and 99% had 42-day follow-up. Furthermore, we facilitated earlier enrollment of women during pregnancy while achieving more timely follow-up and decreased time of reporting from the date of the pregnancy event. Conclusions: We created a pregnancy-related registry which includes demographic data, risk factors, and outcomes allowing for high rates of ascertainment and follow-up while working within the existing health system. Understanding the elements of the system used to create the registry is important to improve the quality of the results. Tracking of pregnancies and their outcomes is an important step toward reducing maternal and perinatal mortality. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
6. Data quality monitoring and performance metrics of a prospective, population-based observational study of maternal and newborn health in low resource settings.
- Author
-
Goudar, Shivaprasad S., Stolka, Kristen B., Koso-Thomas, Marion, Honnungar, Narayan V., Mastiholi, Shivanand C., Ramadurg, Umesh Y., Dhaded, Sangappa M., Pasha, Omrana, Patel, Archana, Esama, Fabian, Chomba, Elwyn, Garces, Ana, Althabe, Fernando, Carlo, Waldemar A., Goldenberg, Robert L., Hibberd, Patricia L., Liechty, Edward A., Krebs, Nancy F., Hambidge, Michael K., and Moore, Janet L.
- Subjects
EVALUATION of medical care ,STATISTICAL standards ,LONGITUDINAL method ,SCIENTIFIC observation ,PREGNANCY ,QUALITY assurance ,DATA analysis ,CONTENT mining - Abstract
Background: To describe quantitative data quality monitoring and performance metrics adopted by the Global Network's (GN) Maternal Newborn Health Registry (MNHR), a maternal and perinatal population-based registry (MPPBR) based in low and middle income countries (LMICs). Methods: Ongoing prospective, population-based data on all pregnancy outcomes within defined geographical locations participating in the GN have been collected since 2008. Data quality metrics were defined and are implemented at the cluster, site and the central level to ensure data quality. Quantitative performance metrics are described for data collected between 2010 and 2013. Results: Delivery outcome rates over 95% illustrate that all sites are successful in following patients from pregnancy through delivery. Examples of specific performance metric reports illustrate how both the metrics and reporting process are used to identify cluster-level and site-level quality issues and illustrate how those metrics track over time. Other summary reports (e.g. the increasing proportion of measured birth weight compared to estimated and missing birth weight) illustrate how a site has improved quality over time. Conclusion: High quality MPPBRs such as the MNHR provide key information on pregnancy outcomes to local and international health officials where civil registration systems are lacking. The MNHR has measures in place to monitor data collection procedures and improve the quality of data collected. Sites have increasingly achieved acceptable values of performance metrics over time, indicating improvements in data quality, but the quality control program must continue to evolve to optimize the use of the MNHR to assess the impact of community interventions in research protocols in pregnancy and perinatal health. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
7. A double blinded placebo controlled comparative clinical trial to evaluate the effectiveness of Siddha medicines, Kaba Sura Kudineer (KSK) & Nilavembu Kudineer (NVK) along with standard Allopathy treatment in the management of symptomatic COVID 19 patients - a structured summary of a study protocol for a randomized controlled trial.
- Author
-
Srivastava A, Rengaraju M, Srivastava S, Narayan V, Gupta V, and Upadhayay R
- Subjects
- C-Reactive Protein metabolism, COVID-19 blood, COVID-19 physiopathology, Double-Blind Method, Ferritins blood, Fibrin Fibrinogen Degradation Products metabolism, Hospitalization, Humans, Interleukin-6 blood, L-Lactate Dehydrogenase blood, Length of Stay statistics & numerical data, Randomized Controlled Trials as Topic, SARS-CoV-2, Medicine, Ayurvedic, Plant Preparations therapeutic use, COVID-19 Drug Treatment
- Abstract
Objectives: The primary objectives of the study are to determine the effectiveness of the Kaba Sura Kudineer (KSK) & Nilavembu Kudineer (NVK) along with standard Allopathy Treatment to compared with Placebo (Decaffeinated Tea) with standard Allopathy Treatment in the management of Symptomatic COVID 19 patients and also in reduction of Hospital Stay Time & Changes in Immunological (IL6) and Bio Chemical Markers (Ferritin, CRP, D-Dimer and LDH). The secondary objectives are to evaluate the safety of the trial medicines and their effects in the reduce the risks of the disease. In addition, to document the profile of Symptomatic COVID 19 patients as per Siddha Principles., Trial Design: A Double Blinded, Three arm, Single Centre, Placebo Controlled, Exploratory and comparative Randomized Controlled Trial PARTICIPANTS: Patients who were admitted to the COVID Care Centre at Govt. Institute of Medical Sciences. Noida in India will be recruited. These will be patients with Mild and Moderate symptoms with laboratory confirmed COVID 19 (RT - PCR Tested Positive) aged 18-65, willing and consenting to participate., Intervention and Comparator: Arm I: Decaffeinated Tea (Placebo - similar in taste and appearance to the other Two Decoctions), 60 Ml Morning and Night after Food, along with standard Allopathy Treatment for 10 days. Arm II: Nilavembu Kudineer (The Siddha Medicines which is used as a standard Anti-Viral drug for the past Pandemics by Siddha Physicians) 60 Ml Morning and Night after Food, along with standard Allopathy Treatment for 10 days. Arm III: Kaba Sura Kudineer (The Siddha Medicine which is proposed to be used as a Treatment for COVID 19 based on Siddha Literature) 60 Ml Morning and Night after Food, along with standard Allopathy Treatment for 10 days. The investigational drugs are registered products under the Govt.of India and bought from GMP Certified Manufacturing Units., Main Outcomes: Primary outcomes: 1. Reduction in Viral load of SARS-CoV-2 at the end of treatment (10 days). 2. Time taken to convert Patient from symptomatic to Asymptomatic based on Reduction in clinical symptoms (10 days). 3. Effect of drugs inflammatory markers (IL6,) at the end of treatment (10 days). 4. Reduction in hospital stay time (20 days follow up). (Based on RT PCR CT Value 3
rd , 6th if needed 10th day). (Based on IL 6 Value needed 10th day or IL6 value on turning negative. (entry level/exit level). Secondary outcomes (10 days): 1. Reduction in use of Intensive Supportive Care. 2. Reduction in incidence of complications (Acute Respiratory Distress Syndrome, other systemic complications). 3. MuLBSTA score for viral pneumonia (multinodular infiltration, hypo-lymphocytosis, bacterial co infection, Total Leucocyte Count (TLC ≤ 0.8 x 109 /L), smoking history, hyper-tension and age) score. 4. Laboratory markers (Haematological & Biochemical Markers). 5. Adverse events/effects Siddha-based measurements. 6. Siddha Udaliyal assessment by using Yakkai Ilakkanam (YI) Tool to diagnose body condition for covid-19 patients., Randomisation: The assignment of the participants into 3 Groups will be allocated in 1:1:1 Ratio through randomization Blocks in Microsoft Excel by a Statistician who is not involved in the study. The allocation scheme will be made by another statistician by using a closed envelope after the assessment of eligibility and Informed consent procedures. The groups will be balanced for age and sex with 3:1 Ratio in each group for mild: severe COVID-19 symptoms., Blinding: The Study is Double Blinded. Participants and Investigators were blinded., Numbers to Be Randomized (sample Size): Sample size could not be calculated, Since there are no prior trials on KSK and NVK as a comparative trial. In addition, there are no prior trials on KSK and NVK in this region. A total Number of 120 Patients, 40 each in 3 groups will be recruited in 1:1:1 Ratio., Trial Status: Protocol Number : SCRUND GIMS Noida Study 1,Version: 2.0 Protocol Date : 20.08.2020 The recruitment period is completed for the trial. The Trial started its recruitment on 22.8.2020. We anticipate study including data analysis will finish in January 2021. This is to state that it was a late submission from authors for publication of the protocol to the BMC, after enrolment in the study was over., Trial Registration: The trial protocol was registered with CTRI (Clinical Trial Registry of India) and number is CTRI/2020/08/027286 on 21.08.2020 FULL PROTOCOL: The full Protocol is attached as an additional file, Accessible from the Trials website (Additional file 1). In the interest in expediting dissemination of this material, the familiar formatting has been eliminated. This letter serves as a summary of the key elements of the full protocol. The Study protocol has been reported in accordance with the SPIRIT guidelines.- Published
- 2021
- Full Text
- View/download PDF
8. "If I had known, I would have applied": poor communication, job dissatisfaction, and attrition of rural health workers in Sierra Leone.
- Author
-
Narayan V, John-Stewart G, Gage G, and O'Malley G
- Subjects
- Adult, Communication, Female, Humans, Male, Middle Aged, Rural Population statistics & numerical data, Sierra Leone, Surveys and Questionnaires, Urban Population statistics & numerical data, Career Choice, Health Personnel psychology, Health Personnel statistics & numerical data, Job Application, Job Satisfaction, Rural Health Services organization & administration
- Abstract
Background: Sierra Leone's health outcomes rank among the worst in the world. A major challenge is the shortage of primary healthcare workers (HCWs) in rural areas due to especially high rates of attrition. This study was undertaken to determine the drivers of job dissatisfaction and poor retention among Sierra Leone's rural HCWs., Methods: Interviews were conducted with 58 rural and 32 urban primary HCWs in Sierra Leone's public health sector, complemented by key informant discussions and review of national policy documents. HCW interviews included (1) semi-structured discussion, (2) questionnaire, (3) card sort about HCW priorities, and (4) free-listing of most pressing challenges and needs. Sampling for HCW interviews was stratified purposive, emphasizing rural HCWs., Results: Among 90 HCWs interviewed, 67% were dissatisfied with their jobs (71% rural vs 52% urban) and 61% intended to leave their post (75% rural vs 38% urban). While working and living conditions and remuneration were significant factors, a major reason for rural HCW disenchantment was their inability to access worker rights, benefits, and advancement opportunities. This was caused by HCWs' lack of knowledge about human resource (HR) policies and procedures, as well as ambiguity in many policies and inequitable implementation. HCWs reported feeling neglected and marginalized and perceived a lack of transparency. These issues can be attributed to the absence of systems for regular two-way communication between the Ministry of Health and HCWs; lack of official national documents with up-to-date, clear HR policies and procedures for HCWs; pay statements that do not provide a breakdown of financial allowances and withholdings; and lack of HCW induction., Conclusions: HCWs in Sierra Leone lacked accurate information about entitlements, policies, and procedures, and this was a driver of rural HCW job dissatisfaction and attrition. System-oriented, low-cost initiatives can address these underlying structural causes in Sierra Leone. These issues likely apply to other countries facing HCW retention challenges and should be considered in development of global HCW retention strategies.
- Published
- 2018
- Full Text
- View/download PDF
9. Retention outcomes and drivers of loss among HIV-exposed and infected infants in Uganda: a retrospective cohort study.
- Author
-
Kiyaga C, Narayan V, McConnell I, Elyanu P, Kisaakye LN, Kekitiinwa A, Price M, and Grosz J
- Subjects
- Adult, Ambulatory Care Facilities, Anti-HIV Agents therapeutic use, Clinical Laboratory Techniques statistics & numerical data, Cohort Studies, Early Diagnosis, Female, HIV Infections drug therapy, HIV Infections prevention & control, Humans, Infant, Infectious Disease Transmission, Vertical prevention & control, Pregnancy, Retrospective Studies, Risk Factors, Uganda, Continuity of Patient Care statistics & numerical data, HIV Infections diagnosis, Infectious Disease Transmission, Vertical statistics & numerical data, Lost to Follow-Up
- Abstract
Background: Uganda's HIV Early Infant Diagnosis (EID) program rapidly scaled up testing of HIV-exposed infants (HEI) in its early years. However, little was known about retention outcomes of HEI after testing. Provision of transport refunds to HEI caregivers was piloted at 3 hospitals to improve retention. This study was conducted to quantify retention outcomes of tested HEI, identify factors driving loss-to-follow-up, and assess the effect of transport refunds on HEI retention., Methods: This mixed-methods study included 7 health facilities- retrospective cohort review at 3 hospitals and qualitative assessment at all facilities. The cohort comprised all HEI tested from September-2007 to February-2009. Retention data was collected manually at each hospital. Qualitative methods included health worker interviews and structured clinic observation. Qualitative data was synthesized, analyzed and triangulated to identify factors driving HEI loss-to-follow-up., Results: The cohort included 1268 HEI, with 244 testing HIV-positive. Only 57% (718/1268) of tested HEI received results. The transport refund pilot increased the percent of HEI caregivers receiving test results from 54% (n = 763) to 58% (n = 505) (p = .08). HEI were tested at late ages (Mean = 7.0 months, n = 1268). Many HEI weren't tested at all: at 1 hospital, only 18% (67/367) of HIV+ pregnant women brought their HEI for testing after birth. Among HIV+ infants, only 40% (98/244) received results and enrolled at an ART Clinic. Of enrolled HIV+ infants, only 43% (57/98) were still active in chronic care. 36% (27/75) of eligible HIV+ infants started ART. Our analysis identified 6 categories of factors driving HEI loss-to-follow-up: fragmentation of EID services across several clinics, with most poorly equipped for HEI care/follow-up; poor referral mechanisms and data management systems; inconsistent clinical care; substandard counseling; poor health worker knowledge of EID; long sample-result turnaround times., Discussion: The poor outcomes for HEI and HIV+ infants have highlighted an urgent need to improve retention and linkage to care. To address the identified gaps, Uganda's Ministry of Health and the Clinton Health Access Initiative developed a new implementation model, shifting EID from a lab-based diagnostic service to an integrated clinic-based chronic care model. This model was piloted at 21 facilities. An evaluation is needed.
- Published
- 2018
- Full Text
- View/download PDF
10. Lifestyle factors and the metabolic syndrome in Schizophrenia: a cross-sectional study.
- Author
-
Heald A, Pendlebury J, Anderson S, Narayan V, Guy M, Gibson M, Haddad P, and Livingston M
- Abstract
Background: Cardiometabolic disease is more common in patients with schizophrenia than the general population., Aim: The purpose of the study was to assess lifestyle factors, including diet and exercise, in patients with schizophrenia and estimate the prevalence of metabolic syndrome., Methods: This is a cross-sectional study of a representative group of outpatients with schizophrenia in Salford, UK. An interview supplemented by questionnaires was used to assess diet, physical activity, and cigarette and alcohol use. Likert scales assessed subjects' views of diet and activity. A physical examination and relevant blood tests were conducted., Results: Thirty-seven people were included in the study. 92% of men had central adiposity, as did 91.7% of women (International Diabetes Federation Definition). The mean age was 46.2 years and mean illness duration was 11.6 years. 67.6% fulfilled criteria for the metabolic syndrome. The mean number of fruit and vegetable portions per day was 2.8 ± 1.8. Over a third did not eat any fruit in a typical week. 42% reported doing no vigorous activity in a typical week. 64.9% smoked and in many cigarette use was heavy. The Likert scale showed that a high proportion of patients had insight into their unhealthy lifestyles., Conclusions: Within this sample, there was a high prevalence of poor diet, smoking and inadequate exercise. Many did not follow national recommendations for dietary intake of fruit and vegetables and daily exercise. These factors probably contribute to the high prevalence of metabolic syndrome. Many had insight into their unhealthy lifestyles. Thus, there is potential for interventions to improve lifestyle factors and reduce the risk of cardiometabolic disease.
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.